Arvinas director plans sale of 23,105 shares

Rhea-AI Filing Summary

ARVINAS, INC. (ARVN) received a notice that director Sunil Agarwal intends to rely on Rule 144 to sell up to 23,105 shares of common stock. The shares are tied to a stock option exercise for cash, with sale information listing an aggregate market value of $196,242.32 and a proposed sale date of September 22, 2026 through Morgan Stanley Smith Barney LLC on NASDAQ.

Key Figures

Shares to be sold: 23,105 shares Aggregate market value: $196,242.32 Proposed sale date: September 22, 2026 +2 more

5 metrics

Shares to be sold 23,105 shares Common stock covered by the Rule 144 notice

Aggregate market value $196,242.32 Reported for the 23,105 shares of common stock

Proposed sale date September 22, 2026 Date shown in Securities Information and Securities To Be Sold

Security type Common stock Securities listed in the Form 144 filing

Number of transactions listed 1 Single common stock line item in the securities sections

Key Terms

Rule 144, Stock Option Exercise, aggregate market value, CUSIP

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Common | 09/22/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common ... | 23105 | 196242.32 | 65386191 | 09/22/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

CUSIP financial

"Common ... | 23105 | 196242.32 | 65386191 | 09/22/2026"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for ARVN?

It discloses that director Sunil Agarwal plans to sell up to 23,105 shares of ARVINAS, INC. common stock under Rule 144, with the shares related to a stock option exercise for cash and a proposed sale date of September 22, 2026.

How many ARVN shares are covered by Sunil Agarwal’s planned Rule 144 sale?

The notice covers up to 23,105 shares of ARVINAS, INC. common stock, as listed in the Securities Information and Securities To Be Sold sections of the Form 144 filing.

What is the reported value of the ARVN shares in this Form 144?

The filing reports an aggregate market value of $196,242.32 for the 23,105 shares of ARVINAS, INC. common stock referenced in the Rule 144 notice.

When is the proposed sale date for the ARVN shares under this Form 144?

The proposed sale date listed for the ARVINAS, INC. shares is September 22, 2026, which appears both in the Securities Information section and in the Securities To Be Sold section.

How will the ARVN shares be obtained for the Rule 144 sale?

The filing states that the common shares are tied to a Stock Option Exercise, with the transaction type shown as “Stock Option Exercise” and the consideration listed as Cash in the Securities To Be Sold section.

Which broker is listed for the ARVN Rule 144 sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, in the Securities Information section of the Form 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/22/2026 - 04:36 PM Accepted by SEC EDGAR 09/22/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001616640
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARVINAS, INC.
SEC File Number	001-38672
Address of Issuer	5 Science Park 395 Winchester Ave. New Haven CONNECTICUT 06511
Phone	(203) 535-1456
Name of Person for Whose Account the Securities are To Be Sold	SUNIL AGARWAL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	23105	196242.32	65386191	09/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/22/2026	Stock Option Exercise	Issuer			23105	09/22/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sunil Agarwal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)